Immunoassay
OwnerSeymon Bystryakinventor
Life of this patent
Estimating the term…
Abstract
There is provided an assay of enhanced sensitivity for the qualitative and quantitative determination of haptens. These may be assayed entities such as antigens, antibodies, a wide variety of biologically active proteins. The novel assay of increased sensitivity is based on the formation of a complex of the entity to be measured with another entity, tagging this conjugate with a oxidizing entity, reacting the resultant entity with a redox substrate to form a product which is photosensitive and irradiating same thus enhancing the sensitivity of the assay. Colored or fluorescent products give highly sensitive results. According to a preferred embodiment the oxidized entity is reacted with a non-ionic detergent, enhancing the resulting fluorescence.
Claims11
A heterologous assay for the determination of an analyte in an aqueous sample which comprises:
- binding a first entity having an affinity for the analyte to a solid support;
- bonding the first entity with the analyte to form a complex;
- reacting the first entity:analyte complex with a second entity, which is tagged by an enzyme, to produce a second entity:first entity:analyte complex;
- contacting the second complex with oPD (orthophenylene-diamine) and H.sub.2 O.sub.2 by which oPD is converted to DAP (2,3-diamino-phenazine);
- irradiating the sample with light energy that includes radiation in the range of wavelengths from about 400 to about 500 nm, thereby initiating further production of DAP in the sample;
- and
- after irradiating, measuring to quantitate the analyte.
Dependencies are inferred from the claim text.